ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 857

Ultrasound Cut-Off Values for Intima-Media Thickness of Temporal, Facial and Axillary Arteries in Giant Cell Arteritis

Valentin S. Schäfer1, Aaron Juche2, Sofia Ramiro3, Andreas Krause2 and Wolfgang A. Schmidt4, 1Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany, 2Medical Centre for Rheumatology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany, 3Department of Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, 4Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: diagnosis, giant cell arteritis, intima medial thickness, ultrasonography and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Abstract

Background/Purpose: Ultrasound (US) is increasingly used in the diagnosis of giant cell arteritis (GCA). US findings mainly rely on morphology (“halo-sign” and “compression sign”). Increasing resolution of modern US probes allows exact intima-media thickness (IMT) measurement of normal and vasculitic temporal arteries. No data have yet been published on IMT of temporal, facial and axillary arteries in GCA patients compared to healthy controls.

Methods:  Fourty newly diagnosed GCA patients of a fast-track GCA clinic and 40 age- and sex-matched controls were included between October 2014 and December 2015. The diagnosis of GCA was established by two very experienced rheumatologists (WAS or AJ) on the basis of clinical presentation, laboratory tests and US results. The diagnosis was confirmed after 6 months in patients who were included until July 2015. IMT measurement was performed at or within 24 hours after the first visit. The common superficial temporal arteries with their frontal and parietal branches and the facial arteries were bilaterally examined with a 10–22 MHz probe (Esaote MyLab Twice). A 6–18 MHz probe was used for both axillary arteries. In total, IMT measurement was performed at 800 sites. The mean IMT values of the different arteries were compared between controls and patients with active vasculitis of the corresponding artery by means of a Mann-Whitney test. ROC analysis was performed to determine the best cut-off value, balancing sensitivity and specificity, to discriminate between a normal and a vasculitic artery.

Results:  Both groups consisted of 40 participants each and included 27 females. The mean age was 72 years (SD 9). Of the 40 GCA patients, 22 (55%) had indurated temporal arteries on clinical examination, 16 (40%) had symptoms of polymyalgia rheumatica. The mean duration of symptoms was 15 weeks (SD 19). Five patients (13%) had visual impairment (anterior ischaemic optic neuropathy, 3; amaurosis fugax, 1; diplopia, 1). Twenty-eight patients (70%) described headache; and 17 (43%) had jaw claudication. The mean ESR was 82 mm/h (SD ± 28); and the mean CRP was 107 mg/l (SD 79). In 26 patients (65%) the axillary arteries were involved of whom 9 had no involvement of temporal arteries. Table 1 shows IMT of affected arteries in GCA patients compared to controls and cut-off values for distinguishing normal from inflamed arteries.  

Artery Vascu-litic arteries consi-dered IMT patients in mm (SD) Control arteries consi-dered IMT controls in mm (SD) Cut-off (mm) Sensitivity Specificity Cor-rectly classi-fied
Common superficial temporal arteries 44 0.65 (0.18) 80 0.23 (0.04) 0.42 100% 100% 100%
Frontal branches 42 0.54 (0.18) 80 0.19 (0.03) 0.34 100% 100% 100%
Parietal branches 36 0.50 (0.17) 78 0.20 (0.03) 0.29 97.2% 98.7% 99.3%
Facial arteries 24 0.53 (0.16) 80 0.24 (0.05) 0.37 87.5 % 98.8% 96.2%
Axillary arteries 46 1.72 (0.41) 80 0.59 (0.10) 1.0 100% 100% 100%

 

Conclusion:  IMT measurement of temporal, facial and axillary arteries can correctly distinguish vasculitic from normal arteries in suspected GCA in addition to morphological parameters. Data for wall diameters are needed for future longitudinal trials to monitor GCA treatment.  


Disclosure: V. S. Schäfer, None; A. Juche, None; S. Ramiro, None; A. Krause, None; W. A. Schmidt, Abbvie, 5,Berlin Chemie, 5,GlaxoSmithKline, 5,Lilly, 5,Novartis Pharmaceutical Corporation, 5,Roche Pharmaceuticals, 5,Abbvie, 8,Berlin Chemie, 8,Medac, 8,Merck Pharmaceuticals, 8,Novartis Pharmaceutical Corporation, 8,Pfizer Inc, 8,Roche Pharmaceuticals, 8,UCB, 8,Abbvie, 2,GlaxoSmithKline, 2,Novartis Pharmaceutical Corporation, 2,Roche Pharmaceuticals, 2.

To cite this abstract in AMA style:

Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA. Ultrasound Cut-Off Values for Intima-Media Thickness of Temporal, Facial and Axillary Arteries in Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/ultrasound-cut-off-values-for-intima-media-thickness-of-temporal-facial-and-axillary-arteries-in-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-cut-off-values-for-intima-media-thickness-of-temporal-facial-and-axillary-arteries-in-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology